[1] |
WU WM, CHEN J, BAI CM, et al. The Chinese guidelines for the diagnosis and treatment of pancreatic neuroendocrine neoplasms (2020)[J]. Med J Peking Union Med Coll Hosp, 2021, 12(4): 460-480. DOI: 10.12290/xhyxzz.2021-0481.
吴文铭, 陈洁, 白春梅, 等. 中国胰腺神经内分泌肿瘤诊疗指南(2020)[J]. 协和医学杂志, 2021, 12(4): 460-480. DOI: 10.12290/xhyxzz.2021-0481.
|
[2] |
SONG JE, KIM BS, LEE CH. Primary hepatic neuroendocrine tumor: A case report and literature review[J]. World J Clin Cases, 2016, 4(8): 243-247. DOI: 10.12998/wjcc.v4.i8.243.
|
[3] |
MENG XF, PAN YW, WANG ZB, et al. Primary hepatic neuroendocrine tumor case with a preoperative course of 26 years: A case report and literature review[J]. World J Gastroenterol, 2018, 24(24): 2640-2646. DOI: 10.3748/wjg.v24.i24.2640.
|
[4] |
EDMONDSON HA. Tumors of the liver and intrahepatic bile ducts[M]. Washington: Armed Fores Institute of Pathology, 1958: 105-109.
|
[5] |
BASUROY R, BOUVIER C, RAMAGE JK, et al. Delays and routes to diagnosis of neuroendocrine tumours[J]. BMC Cancer, 2018, 18(1): 1122. DOI: 10.1186/s12885-018-5057-3.
|
[6] |
IWAO M, NAKAMUTA M, ENJOJI M, et al. Primary hepatic carcinoid tumor: case report and review of 53 cases[J]. Med Sci Monit, 2001, 7(4): 746-750.
|
[7] |
LV Y, HUANG C, XU H, et al. Clinicopathological characteristics of the primary and metastatic hepatic neuroendocrine tumors and the relevant prognosis-related factors: A retrospective study of 81 cases in a single Chinese center[J]. J Cancer, 2018, 9(3): 479-487. DOI: 10.7150/jca.22157.
|
[8] |
ZHENG QF, HE ZJ, NONG B. Advance in diagnosis of primary hepatic neuroendocrine neoplasms[J]. Chin J Gastroenterol, 2018, 23(8): 506-508. DOI: 10.3969/j.issn.1008-7125.2018.08.013.
郑琴芳, 何志钧, 农兵. 原发性肝脏神经内分泌肿瘤诊断的研究进展[J]. 胃肠病学, 2018, 23(8): 506-508. DOI: 10.3969/j.issn.1008-7125.2018.08.013.
|
[9] |
Chinese Society of Clinical Oncology Guidelines Working Committee. The Chinese Society of Clinical Oncology (CSCO): Clinical Guildlines for the Diagnosis and Treatment of Neuroendocrine Neoplasms, 2021[M]. Beijing: People's Medical Publishing House, 2021: 51.
中国临床肿瘤学会指南工作委员会. CSCO神经内分泌肿瘤诊疗指南2021[M]. 北京: 人民卫生出版社, 2021: 51.
|
[10] |
SONG S, KOH Y. Primary hepatic neuroendocrine tumor arising at a young age: Rare case report and literature review[J]. Korean J Gastroenterol, 2022, 79(1): 35-40. DOI: 10.4166/kjg.2021.139.
|
[11] |
ZHAO S, CHENG C, ZUO CJ. The clinical value of combined 68Ga-SSA/18F-FDG PET/CT imaging in neuroendocrine neoplasms[J]. Chin J Nucl Med Mol Imaging, 2020, 40(1): 47-51. DOI: 10.3760/cma.j.issn.2095-2848.2020.01.012.
赵帅, 程超, 左长京. 68Ga-SSA/18F-FDG PET/CT联合显像在神经内分泌肿瘤诊治中的应用价值[J]. 中华核医学与分子影像杂志, 2020, 40(1): 47-51. DOI: 10.3760/cma.j.issn.2095-2848.2020.01.012.
|
[12] |
KNOX CD, ANDERSON CD, LAMPS LW, et al. Long-term survival after resection for primary hepatic carcinoid tumor[J]. Ann Surg Oncol, 2003, 10(10): 1171-1175. DOI: 10.1245/aso.2003.04.533.
|